Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 127.65
    Last
  • 0.07  0.05%
    Today's Change
  • 127.58
    Previous Close
  • Today
     
    96.93
    139.00
    52 Week Low - High
8:10 pm ET 8/18/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding782 million
Market Cap$100 billion
Return on Equity ttm37.19%
Last DividendCELG:US does not pay a dividend
Earnings
EPS: Year Actual ttm5.072
EPS: Year Est. 12/17 ttm7.343
 
EPS: Quarterly Actual 6/17 1.82
EPS: Quarterly Est. 9/17 1.88
 
Price/Earnings ttm25.17
Relative Price/Earnings1.211
Earnings Growth Rate27.23
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$11 billion
Net Income$2 billion
Total Assets$28 billion
Employees7,132
Web Sitewww.celgene.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!